Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 


Widely used medicicines increase risk of rare kidney disease

Widely used heartburn and peptic ulcer medicines increase risk of rare kidney disease: Otago research


New Zealanders taking a proton pump inhibitor (PPI), a type of medicine used to treat gastric acid reflux disorders and peptic ulcer disease, are at an increased risk of a rare kidney disease, according to new findings by University of Otago researchers.

In a newly published study in the journal Kidney International, the researchers found that people who were currently taking a PPI (omeprazole, pantoprazole, or lansoprazole) were about five times more likely to be admitted to hospital with interstitial nephritis than similar people who were past users of a PPI.

Study co-author Dr Lianne Parkin says that interstitial nephritis is a rare, but potentially serious condition, involving inflammation of the kidney tissue.

“While PPIs have been shown to be an effective treatment for gastro-oesophageal reflux and peptic ulcer diseases, there is also evidence, from New Zealand and overseas, which suggests these drugs are sometimes inappropriately prescribed.

“Previous studies have suggested that PPIs increase the risk of interstitial nephritis, however our study is the largest to date and the first to confirm the relationship. We were also able to calculate the absolute risk associated with these drugs, which provides useful information for patients and doctors,” says Dr Parkin. “For example, for every 100,000 people taking a PPI, we found that about 12 per year developed interstitial nephritis as compared with 2 per 100,000 among past users.”

“The excess risk of interstitial nephritis we observed in current users of PPIs, although low in absolute terms, is important from a population perspective as PPIs are one of the most widely prescribed groups of drugs – for instance, about 20% of the New Zealand population was dispensed a PPI at least once between 2005 and 2009. In addition, New Zealanders have been able to purchase a PPI over the counter, without medical advice, since late 2009,” says Dr Parkin.

The researchers used routinely collected health and prescription medicine data to conduct a study based on 572,661 people of all ages who were dispensed omeprazole, pantoprazole, or lansoprazole at any time between 2005 and 2009. Patients with pre-existing kidney disease were excluded from the study, and other potential influences, including age, sex, and other medical conditions and prescription drugs, were taken into account in the analyses.

“Although the PPIs included in our study are extremely safe for the vast majority of users,” says Dr Parkin, “it is important for prescribers to be aware of this increased risk of interstitial nephritis, and for patients to seek appropriate advice before using these medicines.”

The research was funded by Medsafe and the Health Research Council of New Zealand.

Ends

© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

Trade Plans: Prime Minister's Speech To International Business Forum

"The work to improve public services, build infrastructure, and solve social problems is possible only because we have enjoyed sustained, solid economic growth. A big reason for that is the Government’s consistent agenda of economic reform, and our determination to open up more opportunities for trade with the world." More>>

ALSO:

Media: TVNZ Flags Job Cuts To Arrest Profit Decline

Chief executive Kevin Kenrick said the changes were aimed at creating "a sustainable future video content business for TVNZ in an ever-changing media market." More>>

ALSO:

Reserve Bank: Wheeler Keeps OCR At 1.75%

Reserve Bank governor Graeme Wheeler kept the official cash rate unchanged at 1.75 percent, as expected, and reiterated his view that the benchmark rate doesn't need shifting for the foreseeable future. More>>

ALSO:

Retail: Pumpkin Patch Brand, IP Sold To Catch Group

The receivers of failed children's clothing retailer Pumpkin Patch have confirmed that the company's brand and intellectual property have been sold to Australian online retailer Catch Group. More>>

ALSO:

Oil: 2017 Block Offer Petroleum Tender Launched

New Zealand is well-placed to take advantage of the economic benefits of oil and gas exploration, Energy and Resources Minister Judith Collins announced today at the launch of the 2017 Block Offer petroleum tender. More>>

ALSO:

Get More From Scoop

 
 
 
 
 
 
 
 
Sci-Tech
Search Scoop  
 
 
Powered by Vodafone
NZ independent news